Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

NCT05613296 · clinicaltrials.gov ↗

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

ITP - Immune Thrombocytopenia
Chronic ITP
Refractory ITP

Interventions

DRUG: Fostamatinib

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto